Paper39092437
Affinity enhancement of polo-like kinase 1 polo box domain-binding ligands by a bivalent approach using a covalent kinase-binding component.
Tsuji K and 2 others. RSC Chem Biol, 2024. Cited by 5 papers, by iCite.
Cite this record
ConductScience Library. Affinity enhancement of polo-like kinase 1 polo box domain-binding ligands by a bivalent approach using a covalent kinase-binding component. Papers, record 39092437. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/39092437
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Affinity enhancement of polo-like kinase 1 polo box domain-binding ligands by a bivalent approach using a covalent kinase-binding component.
- PubMed
Topics0
NLM's MeSH indexing of the paper, its major topics first.
None in this release.
References49
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 30395539 | PLK1: a promising and previously unexplored target in double-hit lymphoma. | J Clin Invest | 2018 | https://conductscience.org/library/papers/30395539 | PubMed |
| 2 | 26662918 | Inhibitors of the Polo-Box Domain of Polo-Like Kinase 1. | Chembiochem | 2016 | https://conductscience.org/library/papers/26662918 | PubMed |
| 3 | 23159568 | Non-proteinogenic amino acids in the pThr-2 position of a pentamer peptide that confer high binding affinity for the polo box domain (PBD) of polo-like kinase 1 (Plk1). | Bioorg Med Chem Lett | 2012 | https://conductscience.org/library/papers/23159568 | PubMed |
| 4 | 22570300 | Peptoid-Peptide hybrid ligands targeting the polo box domain of polo-like kinase 1. | Chembiochem | 2012 | https://conductscience.org/library/papers/22570300 | PubMed |
| 5 | 28721210 | Current progress and future perspectives in the development of anti-polo-like kinase 1 therapeutic agents. | F1000Res | 2017 | https://conductscience.org/library/papers/28721210 | PubMed |
| 6 | 31014020 | Development of Highly Selective 1,2,3-Triazole-containing Peptidic Polo-like Kinase 1 Polo-box Domain-binding Inhibitors. | Molecules | 2019 | https://conductscience.org/library/papers/31014020 | PubMed |
| 7 | 22625413 | Reversible Michael additions: covalent inhibitors and prodrugs. | Mini Rev Med Chem | 2012 | https://conductscience.org/library/papers/22625413 | PubMed |
| 8 | 17379147 | Covalent reactions of wortmannin under physiological conditions. | Chem Biol | 2007 | https://conductscience.org/library/papers/17379147 | PubMed |
| 9 | 30174151 | Histidine N(τ)-cyclized macrocycles as a new genre of polo-like kinase 1 polo-box domain-binding inhibitors. | Bioorg Med Chem Lett | 2018 | https://conductscience.org/library/papers/30174151 | PubMed |
| 10 | 33175531 | Uncoupling the Folding-Function Paradigm of Lytic Peptides to Deliver Impermeable Inhibitors of Intracellular Protein-Protein Interactions. | J Am Chem Soc | 2020 | https://conductscience.org/library/papers/33175531 | PubMed |
| 11 | 33730624 | Recent advances in development of hetero-bivalent kinase inhibitors. | Eur J Med Chem | 2021 | https://conductscience.org/library/papers/33730624 | PubMed |
| 12 | 27330107 | Plk1 Inhibitors in Cancer Therapy: From Laboratory to Clinics. | Mol Cancer Ther | 2016 | https://conductscience.org/library/papers/27330107 | PubMed |
| 13 | 37433100 | Structural Basis for Variations in Polo-like Kinase 1 Conformation and Intracellular Stability Induced by ATP-Competitive and Novel Noncompetitive Abbapolin Inhibitors. | ACS Chem Biol | 2023 | https://conductscience.org/library/papers/37433100 | PubMed |
| 14 | 21765407 | Serendipitous alkylation of a Plk1 ligand uncovers a new binding channel. | Nat Chem Biol | 2011 | https://conductscience.org/library/papers/21765407 | PubMed |
| 15 | 19774589 | Bisubstrate inhibitors of protein kinases: from principle to practical applications. | ChemMedChem | 2010 | https://conductscience.org/library/papers/19774589 | PubMed |
| 16 | 22292814 | Identification of high affinity polo-like kinase 1 (Plk1) polo-box domain binding peptides using oxime-based diversification. | ACS Chem Biol | 2012 | https://conductscience.org/library/papers/22292814 | PubMed |
| 17 | 19597481 | Structural and functional analyses of minimal phosphopeptides targeting the polo-box domain of polo-like kinase 1. | Nat Struct Mol Biol | 2009 | https://conductscience.org/library/papers/19597481 | PubMed |
| 18 | 24564382 | Bivalent inhibitors of protein kinases. | Crit Rev Biochem Mol Biol | 2014 | https://conductscience.org/library/papers/24564382 | PubMed |
| 19 | 16557283 | Targeting polo-like kinase 1 for cancer therapy. | Nat Rev Cancer | 2006 | https://conductscience.org/library/papers/16557283 | PubMed |
| 20 | 15855824 | Overexpression of Polo-like kinase 1 is a common and early event in pancreatic cancer. | Pancreatology | 2005 | https://conductscience.org/library/papers/15855824 | PubMed |
Cited by2
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 5 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 41026045 | Identification of novel potent peptide inhibitors targeting the polo-box domain of PLK1: structure-based pharmacophore modelling, virtual screening, molecular docking, molecular dynamics study and biological evaluation. | J Enzyme Inhib Med Chem | 2025 | https://conductscience.org/library/papers/41026045 | PubMed |
| 39764864 | Fine-tuning probes for fluorescence polarization binding assays of bivalent ligands against polo-like kinase 1 using full-length protein. | Bioorg Med Chem | 2025 | https://conductscience.org/library/papers/39764864 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PLK1 | 5347 | PubTator's text mining | https://conductscience.org/library/genes/5347 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/39092437
GET https://conductscience.org/api/papers/v1/39092437/references?page=2